329 related articles for article (PubMed ID: 35049999)
21. Opportunistic Fungal Invasion in COVID-19 Pandemic: A Critical Review in Diagnosis and Management.
Sharma A; Bano G; Malik A; Rasool Y; Manzar S; Singh T; Maity M
Avicenna J Med; 2023 Jul; 13(3):131-137. PubMed ID: 37799179
[TBL] [Abstract][Full Text] [Related]
22. A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit.
White PL; Dhillon R; Cordey A; Hughes H; Faggian F; Soni S; Pandey M; Whitaker H; May A; Morgan M; Wise MP; Healy B; Blyth I; Price JS; Vale L; Posso R; Kronda J; Blackwood A; Rafferty H; Moffitt A; Tsitsopoulou A; Gaur S; Holmes T; Backx M
Clin Infect Dis; 2021 Oct; 73(7):e1634-e1644. PubMed ID: 32860682
[TBL] [Abstract][Full Text] [Related]
23. Fungal pathogens and COVID-19.
Singh A; Kaur A; Chowdhary A
Curr Opin Microbiol; 2023 Oct; 75():102365. PubMed ID: 37625261
[TBL] [Abstract][Full Text] [Related]
24. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
[TBL] [Abstract][Full Text] [Related]
25. Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients.
Martin-Loeches I; Nseir S; Rodriguez A; Azoulay E
Curr Opin Pulm Med; 2022 May; 28(3):218-224. PubMed ID: 35152230
[TBL] [Abstract][Full Text] [Related]
26. Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients.
Raffaelli F; Tanzarella ES; De Pascale G; Tumbarello M
J Fungi (Basel); 2022 Apr; 8(4):. PubMed ID: 35448646
[TBL] [Abstract][Full Text] [Related]
27. Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J; Ruiz-Gaitán A; García-Vidal C; Salavert M; Ramírez P; Puchades F; García-Hita M; Alastruey-Izquierdo A; Quindós G
Rev Iberoam Micol; 2020; 37(2):41-46. PubMed ID: 33041191
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary defense mechanisms against opportunistic fungal pathogens.
Waldorf AR
Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
[TBL] [Abstract][Full Text] [Related]
29. The clinical presentation and diagnosis of invasive fungal infections.
Maartens G; Wood MJ
J Antimicrob Chemother; 1991 Jul; 28 Suppl A():13-22. PubMed ID: 1938703
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of Systemic Mycoses in the COVID-19 Pandemic.
Frías-De-León MG; Pinto-Almazán R; Hernández-Castro R; García-Salazar E; Meza-Meneses P; Rodríguez-Cerdeira C; Arenas R; Conde-Cuevas E; Acosta-Altamirano G; Martínez-Herrera E
J Fungi (Basel); 2021 Jul; 7(7):. PubMed ID: 34356935
[TBL] [Abstract][Full Text] [Related]
31. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Segal BH; Herbrecht R; Stevens DA; Ostrosky-Zeichner L; Sobel J; Viscoli C; Walsh TJ; Maertens J; Patterson TF; Perfect JR; Dupont B; Wingard JR; Calandra T; Kauffman CA; Graybill JR; Baden LR; Pappas PG; Bennett JE; Kontoyiannis DP; Cordonnier C; Viviani MA; Bille J; Almyroudis NG; Wheat LJ; Graninger W; Bow EJ; Holland SM; Kullberg BJ; Dismukes WE; De Pauw BE
Clin Infect Dis; 2008 Sep; 47(5):674-83. PubMed ID: 18637757
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
Dupont D; Menotti J; Turc J; Miossec C; Wallet F; Richard JC; Argaud L; Paulus S; Wallon M; Ader F; Persat F
Med Mycol; 2021 Jan; 59(1):110-114. PubMed ID: 32914189
[TBL] [Abstract][Full Text] [Related]
33. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
[TBL] [Abstract][Full Text] [Related]
35. An estimation of burden of serious fungal infections in France.
Gangneux JP; Bougnoux ME; Hennequin C; Godet C; Chandenier J; Denning DW; Dupont B;
J Mycol Med; 2016 Dec; 26(4):385-390. PubMed ID: 27887809
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants.
Ezeokoli OT; Gcilitshana O; Pohl CH
J Fungi (Basel); 2021 Jul; 7(7):. PubMed ID: 34356924
[TBL] [Abstract][Full Text] [Related]
37. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.
Blaize M; Mayaux J; Nabet C; Lampros A; Marcelin AG; Thellier M; Piarroux R; Demoule A; Fekkar A
Emerg Infect Dis; 2020 Jul; 26(7):1636-1637. PubMed ID: 32343223
[TBL] [Abstract][Full Text] [Related]
38. Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients.
Baten N; Wajed S; Talukder A; Masum MHU; Rahman MM
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):64. PubMed ID: 35529527
[TBL] [Abstract][Full Text] [Related]
39. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
[TBL] [Abstract][Full Text] [Related]
40. Burden of serious fungal infections in Ukraine.
Osmanov A; Denning DW
Mycoses; 2015 Oct; 58 Suppl 5():94-100. PubMed ID: 26449513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
